Krystal Wilson
March 10, 2010 | Inside Counsel
Documents Reveal Johnson& Johnson's Plan to Market an Anti-Psychotic as a Dementia Drug to ElderlyLouisiana seeks hundreds of millions of dollars in fines.
By Krystal Wilson
4 minute read
Trending Stories
- 1From 'Confusing Labyrinth' to Speeding 'Rollercoaster': Uncertainty Reigns in Title IX as Litigators Await Second Trump Admin
- 2Critical Mass With Law.com’s Amanda Bronstad: Why Jurors in California Failed to Reach Verdict Over Zantac, Bankruptcy Judge Tables Sanctions Against Beasley Allen Attorney
- 3Jones Day Client Seeks Indemnification for $7.2M Privacy Settlement, Plus Defense Costs
- 4Elections Have Consequences: Some Thoughts on Labor and Employment Law Topics in 2025 and Beyond
- 5Law Firm Associates, Staffers Continue to Put a Premium On Workplace Flexibility, Study Finds
More from ALM
- Legal Speak at General Counsel Conference East 2024: Match Group's Katie Dugan & Herrick's Carol Goodman 1 minute read
- Legal Speak at General Counsel Conference East 2024: Eric Wall, Executive VP, Syllo 1 minute read
- Legal Speak at General Counsel Conference East 2024: Virginia Griffith, Director of Business Development at OutsideGC 1 minute read